GSM Foils Q1 FY26 Concall Decoded: From Foil Wraps to Full-Blown Pharma Play
1. Opening Hook
SMEs usually brag about “double-digit growth.” GSM Foils decided that was too boring—they clocked 148% revenue growth YoY. Even their PAT grew 174%, as if aluminium prices were just a minor inconvenience. The twist? No fancy contracts, no hedging, just a “buy on advance, sell on credit” jugglery that could make even a bank treasurer sweat.
And if that wasn’t enough, they’re already whispering about an Ahmedabad plant, Lamitube expansion, and hitting ₹250 crore revenue in FY26. Sounds like an SME dreaming big—or a David ready to tackle China’s Goliath in pharma packaging. Let’s peel back the foil and see what’s really inside.
2. At a Glance
Revenue ₹52 cr, up 148% YoY – Doubled faster than Maggi claims “2 minutes.”
EBITDA ₹5.8 cr, up 171% – Margins at 11.2%, aluminium prices couldn’t dent the shine.
PAT ₹3.8 cr, up 174% – Net margin 7.37%, pharma foils working like steroids.
Capacity utilization ~65–68% – Machines still have 30–40% juice left.
Debt ₹23–24 cr – Mostly DBH Bank & Tata Capital, more ₹12–15 cr planned.